Evaluation & the Health Professions

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

The Diabetes Educator

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, L. A.
Right arrow Articles by Tierney, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, L. A.
Right arrow Articles by Tierney, J. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Evaluation & the Health Professions, Vol. 25, No. 1, 76-97 (2002)
DOI: 10.1177/0163278702025001006

To IPD or not to IPD?

Advantages and Disadvantages of Systematic Reviews Using Individual Patient Data

Lesley A. Stewart

Jayne F. Tierney

MRC Clinical Trials Unit

Systematic reviews and meta-analyses that obtain original research data on individual participants enrolled in trials have been described as the gold standard of review. However, they may take longer and be more resource intensive than other types of review. The authors describe potential advantages and disadvantages of the individual patient data (IPD) approach, including benefits from improved data quality, benefits afforded by the type of analyses that can be done, and advantages in achieving consensus around results and interpretation by an international multi disciplinary team. Disadvantages and barriers relating to resource and expertise, negotiating collaboration, and software requirements are also discussed. At the outset, reviewers should consider the methodological factors likely to influence results in their particular review setting, together with time and resource constraints, so that an active decision can be made about whether to extract data frompublished reports, collect addi tional or replacement summary data from trialists, or collect IPD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. A. Alsheikh-Ali, T. A. Trikalinos, D. M. Kent, and R. H. Karas
Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer
J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1141 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
J. van der Steen, R. Kruse, K. Szafara, D. Mehr, G van der Wal, M. Ribbe, and R. D'Agostino
Benefits and pitfalls of pooling datasets from comparable observational studies: combining US and Dutch nursing home studies
Palliative Medicine, September 1, 2008; 22(6): 750 - 759.
[Abstract] [PDF]


Home page
Sex. Transm. Infect.Home page
The eligibility for ART in lower income countries
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
Sex. Transm. Inf., August 1, 2008; 84(Suppl_1): i31 - i36.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Koopman, G. J. M. G. van der Heijden, D. E. Grobbee, and M. M. Rovers
Comparison of Methods of Handling Missing Data in Individual Patient Data Meta-analyses: An Empirical Example on Antibiotics in Children with Acute Otitis Media
Am. J. Epidemiol., March 1, 2008; 167(5): 540 - 545.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. L. Helman Jr, A. W. Brown, J. L. Jackson, and A. F. Shorr
Analyzing the Short-term Effect of Placebo Therapy in Pulmonary Arterial Hypertension: Potential Implications for the Design of Future Clinical Trials
Chest, September 1, 2007; 132(3): 764 - 772.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Kastrati, J. Mehilli, J. Pache, C. Kaiser, M. Valgimigli, H. Kelbaek, M. Menichelli, M. Sabate, M. J. Suttorp, D. Baumgart, et al.
Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
N. Engl. J. Med., March 8, 2007; 356(10): 1030 - 1039.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Mauri, N. Pavlidis, N. P. Polyzos, and J. P. A. Ioannidis
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
J Natl Cancer Inst, September 20, 2006; 98(18): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
R. P Rietveld, P. J E Bindels, and G. ter Riet
Antibiotics for upper respiratory tract infections and conjunctivitis in primary care
BMJ, August 12, 2006; 333(7563): 311 - 312.
[Full Text] [PDF]


Home page
Clin TrialsHome page
M. C Simmonds, J. P T Higginsa, L. A Stewartb, J. F Tierneyb, M. J Clarke, and S. G Thompson
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
Clinical Trials, June 1, 2005; 2(3): 209 - 217.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Burdett, L. Stewart, and J.-P. Pignon
Chemotherapy in non-small cell lung cancer: An update of an individual patient data-based meta-analysis
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1205 - 1205.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
M M Rovers, N Black, G G Browning, R Maw, G A Zielhuis, and M P Haggard
Grommets in otitis media with effusion: an individual patient data meta-analysis
Arch. Dis. Child., May 1, 2005; 90(5): 480 - 485.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Mauri, N. Pavlidis, and J. P. A. Ioannidis
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
J Natl Cancer Inst, February 2, 2005; 97(3): 188 - 194.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
J. F Tierney and L. A Stewart
Investigating patient exclusion bias in meta-analysis
Int. J. Epidemiol., February 1, 2005; 34(1): 79 - 87.
[Abstract] [Full Text] [PDF]